WFPL: ‘Dark Waters’ Puts Contaminants Saga for Ohio River on Big Screen
UC scientist warns against dangers of PFOA
Louisville, Kentucky public radio station WFPL looks at the dangers of the drinking water contaminate, perfluorooctanoic acid or PFOA, in the wake of the Hollywood film “Dark Waters.” The environmental thrillerdepicts the real-life story of the 20-year battle waged by Cincinnati attorney Rob Bilott against chemical giant DuPont. Bilott, played by actor Mark Ruffalo, as a young corporate defense lawyer living in Cincinnati. His grandmother, who lives in Parkersburg, West Virginia, gives his phone number to local farmer, Earl Tennant. Tennant lives next to a landfill.
WFPL interviewed Susan Pinney, professor in the University of Cincinnati College of Medicine’s Department of Environmental Health, about the effects of PFOA and its possible presence in the drinking water of communities across the nation. One group estimates up to 110 million Americans drink water with dangerous levels of contaminants. Pinney said granular activated carbon filtration systems need to be installed in water treatment facilities to remove the PFOA threat from drinking water. “To me where we’re at right now, we’re soon going to find that there are a whole lot more communities with exposed people than anyone thought,” said Pinney.
Other media in Greater Cincinnati also covered the tie between 'Dark Waters' and Pinney's research.
Listen to the WFPL interview online
Read a Dayton Daily News interview online
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.
Celebrating the newest Bearcats on Decision Day
December 11, 2025
The University of Cincinnati admits its newest Bearcats for Fall 2026. Interest in the university is at an all-time high with more than 35,000 applicants for admission. Decision Day was also a time to celebrate 10 new Marian Spencer Scholarship recipients.